- Home
- ACHV vs BARK Comparison
ACHV vs BARK Comparison
Compare ACHV & BARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHV | BARK |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.6M | 146.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ACHV | BARK |
|---|---|---|
| Price | $4.88 | $0.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $15.50 | $2.50 |
| AVG Volume (30 Days) | 686.8K | ★ 868.0K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $451,690,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.84 | $0.66 |
| 52 Week High | $5.78 | $2.56 |
Technical Indicators
Market Signals| Indicator | ACHV | BARK |
|---|---|---|
| Relative Strength Index (RSI) | 60.25 | 40.96 |
| Support Level | $3.82 | $0.66 |
| Resistance Level | $4.99 | $0.73 |
| Average True Range (ATR) | 0.32 | 0.05 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 90.17 | 29.79 |
Price Performance
Historical ComparisonAbout ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.